Wei Zhou1, Brittanie D Baughman2, Salil Soman3, Max Wintermark4, Laura C Lazzeroni5, Elizabeth Hitchner2, Jyoti Bhat6, Allyson Rosen7. 1. Vascular Surgery, VA Palo Alto Health Care System, Palo Alto, Calif; Department of Surgery, Stanford University, Stanford, Calif. Electronic address: weizhou@stanford.edu. 2. Vascular Surgery, VA Palo Alto Health Care System, Palo Alto, Calif. 3. Department of Radiology, Harvard Medical School, Cambridge, Mass. 4. Department of Radiology, Stanford University, Stanford, Calif. 5. Department of Psychiatry and Behavior Science, Stanford University, Stanford, Calif. 6. Department of Psychiatry, VA Palo Alto Health Care System, Palo Alto, Calif. 7. Department of Psychiatry and Behavior Science, Stanford University, Stanford, Calif; Department of Psychiatry, VA Palo Alto Health Care System, Palo Alto, Calif.
Abstract
OBJECTIVE: Carotid intervention is safe and effective in stroke prevention in appropriately selected patients. Despite minimal neurologic complications, procedure-related subclinical microemboli are common and their cognitive effects are largely unknown. In this prospective longitudinal study, we sought to determine long-term cognitive effects of embolic infarcts. METHODS: The study recruited 119 patients including 46% symptomatic patients who underwent carotid revascularization. Neuropsychological testing was administered preoperatively and at 1 month, 6 months, and 12 months postoperatively. Rey Auditory Verbal Learning Test (RAVLT) was the primary cognitive measure with parallel forms to avoid practice effect. All patients also received 3T brain magnetic resonance imaging with a diffusion-weighted imaging (DWI) sequence preoperatively and within 48 hours postoperatively to identify procedure-related new embolic lesions. Each DWI lesion was manually traced and input into a neuroimaging program to define volume. Embolic infarct volumes were correlated with cognitive measures. Regression models were used to identify relationships between infarct volumes and cognitive measures. RESULTS: A total of 587 DWI lesions were identified on 3T magnetic resonance imaging in 81.7% of carotid artery stenting (CAS) and 36.4% of carotid endarterectomy patients with a total volume of 29,327 mm3. Among them, 54 DWI lesions were found in carotid endarterectomy patients and 533 in the CAS patients. Four patients had transient postoperative neurologic symptoms and one had a stroke. CAS was an independent predictor of embolic infarction (odds ratio, 6.6 [2.1-20.4]; P < .01) and infarct volume (P = .004). Diabetes and contralateral carotid severe stenosis or occlusion had a trend of positive association with infarct volume, whereas systolic blood pressure ≥140 mm Hg had a negative association (P = .1, .09, and .1, respectively). There was a trend of improved RAVLT scores overall after carotid revascularization. Significantly higher infarct volumes were observed among those with RAVLT decline. Within the CAS cohort, infarct volume was negatively correlated with short- and long-term RAVLT changes (P < .05). CONCLUSIONS: Cognitive assessment of procedure-related subclinical microemboli is challenging. Volumes of embolic infarct correlate with long-term cognitive changes, suggesting that microembolization should be considered a surrogate measure for carotid disease management. Published by Elsevier Inc.
OBJECTIVE: Carotid intervention is safe and effective in stroke prevention in appropriately selected patients. Despite minimal neurologic complications, procedure-related subclinical microemboli are common and their cognitive effects are largely unknown. In this prospective longitudinal study, we sought to determine long-term cognitive effects of embolic infarcts. METHODS: The study recruited 119 patients including 46% symptomatic patients who underwent carotid revascularization. Neuropsychological testing was administered preoperatively and at 1 month, 6 months, and 12 months postoperatively. Rey Auditory Verbal Learning Test (RAVLT) was the primary cognitive measure with parallel forms to avoid practice effect. All patients also received 3T brain magnetic resonance imaging with a diffusion-weighted imaging (DWI) sequence preoperatively and within 48 hours postoperatively to identify procedure-related new embolic lesions. Each DWI lesion was manually traced and input into a neuroimaging program to define volume. Embolic infarct volumes were correlated with cognitive measures. Regression models were used to identify relationships between infarct volumes and cognitive measures. RESULTS: A total of 587 DWI lesions were identified on 3T magnetic resonance imaging in 81.7% of carotid artery stenting (CAS) and 36.4% of carotid endarterectomy patients with a total volume of 29,327 mm3. Among them, 54 DWI lesions were found in carotid endarterectomy patients and 533 in the CASpatients. Four patients had transient postoperative neurologic symptoms and one had a stroke. CAS was an independent predictor of embolic infarction (odds ratio, 6.6 [2.1-20.4]; P < .01) and infarct volume (P = .004). Diabetes and contralateral carotid severe stenosis or occlusion had a trend of positive association with infarct volume, whereas systolic blood pressure ≥140 mm Hg had a negative association (P = .1, .09, and .1, respectively). There was a trend of improved RAVLT scores overall after carotid revascularization. Significantly higher infarct volumes were observed among those with RAVLT decline. Within the CAS cohort, infarct volume was negatively correlated with short- and long-term RAVLT changes (P < .05). CONCLUSIONS: Cognitive assessment of procedure-related subclinical microemboli is challenging. Volumes of embolic infarct correlate with long-term cognitive changes, suggesting that microembolization should be considered a surrogate measure for carotid disease management. Published by Elsevier Inc.
Authors: Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews Journal: Neuroimage Date: 2004 Impact factor: 6.556
Authors: J H Rapp; X M Pan; F R Sharp; D M Shah; G A Wille; P M Velez; A Troyer; R T Higashida; D Saloner Journal: J Vasc Surg Date: 2000-07 Impact factor: 4.268
Authors: J R Meyer; A Gutierrez; B Mock; D Hebron; J M Prager; M T Gorey; D Homer Journal: AJNR Am J Neuroradiol Date: 2000 Nov-Dec Impact factor: 3.825
Authors: Michael Schlüter; Thilo Tübler; Johann C Steffens; Detlef G Mathey; Joachim Schofer Journal: J Am Coll Cardiol Date: 2003-09-17 Impact factor: 24.094
Authors: K O Lövblad; H J Laubach; A E Baird; F Curtin; G Schlaug; R R Edelman; S Warach Journal: AJNR Am J Neuroradiol Date: 1998 Jun-Jul Impact factor: 3.825
Authors: A Altinbas; M J E van Zandvoort; E van den Berg; L M Jongen; A Algra; F L Moll; P J Nederkoorn; W P T M Mali; L H Bonati; M M Brown; L J Kappelle; H B van der Worp Journal: Neurology Date: 2011-08-31 Impact factor: 9.910
Authors: Carmen Serna Candel; Marta Aguilar Pérez; Victoria Hellstern; Muhammad AlMatter; Hansjörg Bäzner; Hans Henkes Journal: Cerebrovasc Dis Date: 2019-11-20 Impact factor: 2.762
Authors: Magdalena Piegza; Izabela Jaworska; Jacek Piegza; Kamil Bujak; Paweł Dębski; Aleksandra Leksowska; Piotr Gorczyca; Mariusz Gąsior; Robert Pudlo Journal: J Clin Med Date: 2022-05-27 Impact factor: 4.964
Authors: Juan C Arias; Mark Edwards; Francesca Vitali; Thomas G Beach; Geidy E Serrano; Craig C Weinkauf Journal: J Vasc Surg Date: 2021-08-31 Impact factor: 4.268